Register entry

Recordati Rare Diseases

Registered sites
1
Drug products
21
Live patents
37
Countries
1
Base
France
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Finished drug manufacture
Sites

Facilities

1
SiteLocationOperationsFEI
Recordati Rare DiseasesPuteauxFranceFinished drug manufacture3008341412
Exclusivity

Patents

37

Unexpired Orange Book patents where this company is the application holder.

ProductActive ingredientExpiry
ISTURISAOSILODROSTAT PHOSPHATEAug 2026
ISTURISAOSILODROSTAT PHOSPHATEMar 2029
ISTURISAOSILODROSTAT PHOSPHATEJan 2031
ISTURISAOSILODROSTAT PHOSPHATEMay 2033
ISTURISAOSILODROSTAT PHOSPHATEJul 2035
ISTURISAOSILODROSTAT PHOSPHATEOct 2035
NEOPROFENIBUPROFEN LYSINEMar 2032
SIGNIFORPASIREOTIDE DIASPARTATEDec 2026
SIGNIFOR LAR KITPASIREOTIDE PAMOATEOct 2026
SIGNIFOR LAR KITPASIREOTIDE PAMOATEDec 2026
SIGNIFOR LAR KITPASIREOTIDE PAMOATEMay 2028
Catalogue

Marketed products

21

Showing 21 of 21.

BrandGeneric nameFormCategory
CYSTADROPScysteamine hydrochlorideSOLUTIONNDA
CarbagluCarglumic AcidTABLET, FOR SUSPENSIONNDA
ChemetsuccimerCAPSULENDA
CystadanebetainePOWDER, FOR SOLUTIONNDA
Enjaymosutimlimab-jomeINJECTION, SOLUTION, CONCENTRATEBLA
IsturisaosilodrostatTABLET, COATEDNDA
IsturisaOSILODROSTATTABLET, COATEDNDA
IsturisaOsilodrostatTABLET, COATEDNDA
IsturisaOsilodrostatTABLET, COATEDNDA
NEOPROFENibuprofen lysineSOLUTIONNDA
PanhematinheminPOWDER, FOR SOLUTIONBLA
SigniforpasireotideINJECTIONNDA
SigniforpasireotideINJECTIONNDA
SigniforpasireotideINJECTIONNDA
Signifor LARpasireotideKITNDA
Signifor LARpasireotideKITNDA
Signifor LARpasireotideKITNDA
Signifor LARpasireotideKITNDA
Signifor LARpasireotideKITNDA
SylvantSiltuximabINJECTION, POWDER, FOR SOLUTIONBLA
SylvantSiltuximabINJECTION, POWDER, FOR SOLUTIONBLA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.